Ovid Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 5.32 M | $6.27 M | 0.00% | 7.49% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.31 M | $5.09 M | 100.00% | 6.08% |
MADISON AVENUE PARTNERS, LP | 11/14/2024 | 4.12 M | $4.86 M | 0.85% | 5.80% |
BVF INC/IL | 11/14/2024 | 3.85 M | $4.55 M | 0.00% | 5.43% |
VANGUARD GROUP INC | 11/13/2024 | 3.14 M | $3.71 M | 1.72% | 4.43% |
SIREN, L.L.C. | 11/13/2024 | 2.85 M | $3.36 B | 100.00% | 4.02% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.85 M | $2.18 M | 10.98% | 2.60% |
KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.53 M | $1.80 M | 2.65% | 2.15% |
JPMORGAN CHASE & CO | 12/26/2024 | 1.46 M | $1.73 M | -0.18% | 2.06% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.40 M | $1.65 M | 0.00% | 1.97% |
STATE STREET CORP | 11/14/2024 | 1.36 M | $1.61 M | 0.52% | 1.92% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.32 M | $1.55 M | 1.14% | 1.86% |
TLS ADVISORS LLC | 11/12/2024 | 771,531 | $910,000 | -31.44% | 1.09% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 735,185 | $867,518 | -0.87% | 1.04% |
PROSIGHT MANAGEMENT, LP | 11/14/2024 | 729,208 | $860,465 | -32.17% | 1.03% |
UBS OCONNOR LLC | 11/14/2024 | 628,290 | $741,382 | 117.94% | 0.89% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 309,540 | $365,257 | -12.10% | 0.44% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 260,509 | $307,000 | 117.99% | 0.37% |
MORGAN STANLEY | 11/14/2024 | 165,830 | $195,679 | 140.51% | 0.23% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 165,763 | $195,600 | -24.02% | 0.23% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 161,808 | $190,933 | 0.00% | 0.23% |
EMPOWERED FUNDS, LLC | 11/06/2024 | 145,340 | $171,501 | 5.34% | 0.20% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 130,279 | $153,729 | 2.72% | 0.18% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 119,113 | $140,553 | 0.00% | 0.17% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 104,011 | $122,733 | -62.18% | 0.15% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 86,289 | $101,821 | 100.00% | 0.12% |
BARCLAYS PLC | 11/19/2024 | 84,175 | $98,000 | 311.15% | 0.12% |
VERITION FUND MANAGEMENT LLC | 11/14/2024 | 74,875 | $88,353 | 100.00% | 0.11% |
RHUMBLINE ADVISERS | 11/12/2024 | 68,723 | $81,088 | -1.45% | 0.10% |
FMR LLC | 11/13/2024 | 50,225 | $59,265 | 1,907.39% | 0.07% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 47,880 | $56,498 | 0.00% | 0.07% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 44,500 | $52,510 | -68.48% | 0.06% |
JANE STREET GROUP, LLC | 11/15/2024 | 38,399 | $45,311 | -61.05% | 0.05% |
XTX TOPCO LTD | 11/14/2024 | 38,230 | $45,111 | 46.17% | 0.05% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 37,892 | $44,712 | 28.30% | 0.05% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 37,743 | $44,537 | 96.68% | 0.05% |
CITADEL ADVISORS LLC | 11/14/2024 | 37,400 | $44,132 | 263.11% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 34,086 | $40,221 | 10.26% | 0.05% |
BLAIR WILLIAM & CO/IL | 11/12/2024 | 32,039 | $37,806 | 3.22% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 31,489 | $37,157 | -0.61% | 0.04% |
UBS GROUP AG | 11/14/2024 | 30,612 | $36,122 | 44.45% | 0.04% |
INVESCO LTD. | 11/12/2024 | 29,337 | $34,618 | 1.69% | 0.04% |
TEJARA CAPITAL LTD | 11/13/2024 | 29,329 | $34,608 | -57.19% | 0.04% |
FIRST MANHATTAN CO. LLC. | 11/14/2024 | 26,000 | $30,680 | 0.00% | 0.04% |
SG AMERICAS SECURITIES, LLC | 10/03/2024 | 20,464 | $24,000 | 100.00% | 0.03% |
NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 18,986 | $22,000 | 0.00% | 0.03% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 17,396 | $21,000 | 0.00% | 0.02% |
NEWMAN DIGNAN & SHEERAR, INC. | 11/12/2024 | 16,522 | $19,331 | 100.00% | 0.02% |
DCF ADVISERS, LLC | 11/13/2024 | 14,750 | $17,405 | -64.67% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 10/25/2024 | 13,650 | $16,107 | 63.77% | 0.02% |
Ovid Therapeutics Inc.institutional Ownership - FAQ's
During the previous two years, 89 institutional investors and hedge funds held shares of Ovid Therapeutics Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 5.32 M
BlackRock Funding, Inc. /DE: 4.31 M
Madison Avenue Partners, LP: 4.12 M
BVF INC/IL: 3.85 M
VANGUARD GROUP INC: 3.14 M
Siren, L.L.C.: 2.85 M
54.66% of Ovid Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44.00 M shares in the last 24 months. This purchase volume represents approximately $43.12 M in transactions.